Cargando…

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2022

Detalles Bibliográficos
Autores principales:	Murthy, Neil, Wodi, A. Patricia, Bernstein, Henry, McNally, Veronica, Cineas, Sybil, Ault, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2022
Materias:	Full Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853474/ https://www.ncbi.nlm.nih.gov/pubmed/35176010 http://dx.doi.org/10.15585/mmwr.mm7107a1

Ejemplares similares

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2022
por: Wodi, A. Patricia, et al.
Publicado: (2022)

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2023
por: Murthy, Neil, et al.
Publicado: (2023)

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2023
por: Wodi, A. Patricia, et al.
Publicado: (2023)

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2021
por: Wodi, A. Patricia, et al.
Publicado: (2021)

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2021
por: Freedman, Mark S., et al.
Publicado: (2021)

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2020
por: Freedman, Mark S., et al.
Publicado: (2020)

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2019
por: Robinson, Candice L., et al.
Publicado: (2019)

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2020
por: Robinson, Candice L., et al.
Publicado: (2020)

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2018
por: Kim, David K., et al.
Publicado: (2018)

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2017
por: Kim, David K., et al.
Publicado: (2017)

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2019
por: Kim, David K., et al.
Publicado: (2019)

Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
por: Rao, Agam K., et al.
Publicado: (2022)

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2018
por: Robinson, Candice L., et al.
Publicado: (2018)

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2017
por: Robinson, Candice L., et al.
Publicado: (2017)

Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
por: Weng, Mark K., et al.
Publicado: (2022)

Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
por: Krow-Lucal, Elisabeth, et al.
Publicado: (2022)

Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine
por: Wong, Karen K., et al.
Publicado: (2017)

Cholera Vaccine: Recommendations of the Advisory Committee on Immunization Practices, 2022
por: Collins, Jennifer P., et al.
Publicado: (2022)

Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021
por: Paz-Bailey, Gabriela, et al.
Publicado: (2021)

Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines
por: Dooling, Kathleen L., et al.
Publicado: (2018)

Updated Framework for Development of Evidence-Based Recommendations by the Advisory Committee on Immunization Practices
por: Lee, Grace, et al.
Publicado: (2018)

Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices
por: Meites, Elissa, et al.
Publicado: (2019)

Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019
por: Havers, Fiona P., et al.
Publicado: (2020)

Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
por: Anderson, Tara C., et al.
Publicado: (2022)

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2015
por: Kim, David K., et al.
Publicado: (2015)

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2014
por: Bridges, Carolyn B., et al.
Publicado: (2014)

Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
por: Kobayashi, Miwako, et al.
Publicado: (2022)

Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022
por: Rosenblum, Hannah G., et al.
Publicado: (2022)

Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Persons Experiencing Homelessness
por: Doshani, Mona, et al.
Publicado: (2019)

Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021
por: Oliver, Sara E., et al.
Publicado: (2022)

Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine — Advisory Committee on Immunization Practices, 2016
por: Patton, Monica E., et al.
Publicado: (2017)

Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years — United States, July 2022
por: Twentyman, Evelyn, et al.
Publicado: (2022)

Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
por: Melgar, Michael, et al.
Publicado: (2023)

Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant
por: Schillie, Sarah, et al.
Publicado: (2018)

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021
por: Oliver, Sara E., et al.
Publicado: (2021)

Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021
por: MacNeil, Jessica R., et al.
Publicado: (2021)

Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices
por: Hills, Susan L., et al.
Publicado: (2019)

Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2015
por: Strikas, Raymond A.
Publicado: (2015)

Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2014
por: Akinsanya-Beysolow, Iyabode
Publicado: (2014)

The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020
por: Dooling, Kathleen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_265k2krrv0bt85rfekr35jti33